News
- Author:
- Randy Dotinga
Publish date: July 1, 2017
SAN DIEGO – A Swedish cohort study associated lab values with a greater likelihood of a type 2 diabetes diagnosis 25 years later.
News
- Author:
- Randy Dotinga
Publish date: June 30, 2017
BOSTON – Seizures and strokes have risen in hospitalized TB meningitis patients.
News
- Author:
- Randy Dotinga
Publish date: June 28, 2017
BOSTON – Patients can test physical, mental skills every few hours.
News
- Author:
- Randy Dotinga
Publish date: June 28, 2017
BOSTON – Investigational carbidopa-levodopa drug improved “on” time.
News
- Author:
- Randy Dotinga
Publish date: June 26, 2017
A new approach for treating ocular rosacea is on its way.
News
- Author:
- Randy Dotinga
Publish date: June 25, 2017
But Novo Nordisk has stopped drug development.
News
- Author:
- Randy Dotinga
Publish date: June 22, 2017
SAN DIEGO – New study results support focus on primary care for meeting the mental health needs of this population.
News
- Author:
- Randy Dotinga
Publish date: June 20, 2017
BOSTON – The degree of improvement has proved to be clinically relevant.
News
- Author:
- Randy Dotinga
Publish date: June 16, 2017
New study supports “continuous monitoring for suicidality” among veterans.
News
- Author:
- Randy Dotinga
Publish date: June 14, 2017
Measures improved across age, gender, and degree of obesity.
News
- Author:
- Randy Dotinga
Publish date: June 12, 2017
BOSTON – The effects of head injuries don’t disappear with the symptoms.
News
- Author:
- Randy Dotinga
Publish date: June 12, 2017
SAN DIEGO – With disappointing results, metformin may not be as useful as previously thought.
News
- Author:
- Randy Dotinga
Publish date: June 11, 2017
Veteran orthopedist provides pearls on tracking the well-being of the feet of patients with diabetes.
News
- Author:
- Randy Dotinga
Publish date: June 9, 2017
SAN DIEGO – The patient’s failure to complete previously recommended pedophilia treatment proves fateful.
Video
- Author:
- Randy Dotinga
Publish date: June 5, 2017
BOSTON – The drug aims to be “the first mechanism-specific, migraine-targeted preventive treatment approach ever.”
